11C-methionine positron emission tomography in brain tumor

Neurological Surgery

Volumn 36, Issue 10, 2008, Pages 847-859

  Kawai, Nobuyuki ^a   Kagawa, Masahiro ^a   Hatakeyama, Tetsuhiro ^a   Tamiya, Takashi ^a   Nishiyama, Yoshihiro ^a   Yamamoto, Yuka ^a   Miki, Akihiro ^a   Ichikawa, Tomotugu ^b  

^a KAGAWA UNIVERSITY   (Japan)

^b OKAYAMA UNIVERSITY   (Japan)

Author keywords

Brain tumor; Glioma; Metastasis; Methionine; Positron emission tomography

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GLUCOSE TRANSPORTER; METHIONINE C 11; CARBON; DIAGNOSTIC AGENT; METHIONINE; RADIOPHARMACEUTICAL AGENT;

ASTROCYTOMA; BLOOD BRAIN BARRIER; BRAIN TUMOR; CANCER GRADING; GLIOBLASTOMA; GLIOMA; HUMAN; IMAGE ENHANCEMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PARIETAL LOBE; POSITRON EMISSION TOMOGRAPHY; REVIEW; ADULT; AGED; CANCER STAGING; MIDDLE AGED; OLIGODENDROGLIOMA; PATHOLOGY; PROGNOSIS; SCINTISCANNING;

ADULT; AGED; ASTROCYTOMA; BRAIN NEOPLASMS; CARBON RADIOISOTOPES; GLIOBLASTOMA; HUMANS; METHIONINE; MIDDLE AGED; NEOPLASM STAGING; OLIGODENDROGLIOMA; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; RADIOPHARMACEUTICALS;

EID: 54249085777     PISSN: 03012603     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (58)

1. 18F] FLT-PET in oncology : current status and opportunities. Eur J Nucl Med Mol Imaging 31 : 1659-1672, 2004
2. Belohlávek O, Simonová G, Kantorová I, Novotný J Jr, Liscák R: Brain metastases after stereotactic radiosurgery using the Leksell gamma knife: can FDG PET help to differentiate radionecrosis from tumour progression? Eur J Nucl Med Mol Imaging 30 : 96-100, 2003
3. 11C-methionine in the determination of malignancy of gliomas. J Neurol Sci 246 : 85-94, 2006
4. 11C methionine positron emission tomography (PET) data-results of a pilot study in 32 surgical cases. Acta Neurochir (Wien) 144 : 777-782, 2002
5. 11C] methionine PET, histopathology, and survival in primary brain tumors and recurrence. AJNR Am J Neuroradiol 27 : 1432-1437, 2006
6. 18F-FDG. J Nucl Med 46 : 945-952, 2005
7. 18F] 3′-deoxy-3′-fluorothymidine PET for the diagnosis and grading of brain tumors. Eur J Nucl Med Mol Imaging 32 : 653-659, 2005
8. 18F-FDG PET. Eur J Nucl Med 29 : 176-182, 2002
9. Derlon JM, Chapon F, Noël MH, Khouri S, Benali K, Petit-Taboué MC, Houtteville JP, Chajari MH, Bouvard G : Non-invasive grading of oligodendrogliomas : correlations between in vivo metabolic pattern and histopathology. Eur J Nucl Med 27 : 778-787, 2000
10. 11C-L-methylmethionine. Neurosurgery 40 : 276-288, 1997
11. De Witte O, Goldberg I, Wikler D, Rorive S, Damhaut P, Monclus M, Salmon I, Brotchi J, Goldman S : Positron emission tomography with injection of methionine as a prognostic factor in glioma. J Neurosurg 95 : 746-750 2001
12. 11C-methionine PET to monitor the effects of temozolomide chemotherapy in malignant gliomas. Eur J Nucl Med Mol Imaging 33 : 516-524, 2006
13. 11C-methionine PET improves the target volume definition of meningiomas treated with stereotactic fractionated radiotherapy. Int J Radiat Oncol Biol Phys 66 : 339-344, 2006
14. Grosu AL, Weber WA, Franz M, Stärk S, Piert M, Thamm R, Gumprecht H, Schwaiger M, Molls M, Nieder C : Reirradiation of recurrent high-grade gliomas using amino acid PET (SPECT)/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy. Int J Radiat Oncol Biol Phys 63 : 511-519, 2005
15. 11C) methionine positron emission tomography for target delineation in resected high-grade gliomas before radiosurgery. Int J Radiat Oncol Biol Phys 63 : 64-74, 2005
16. 18F-fluorothymidine (FLT) PET in patients with newly diagnosed glioma. Eur J Nucl Med Mol Imaging, in press
17. 11C-methionine PET for differential diagnosis of low-grade gliomas. Neurology 50 : 1316-1322, 1998
18. 11F α-methyl tyrosine PET studies in patients with brain tumors. J Nucl Med 40 : 399-405, 1999
19. 11C] methionine uptake in brain abscess : a PET study. J Comput Assist Tomogr 17 : 660-661, 1993
20. Iuchi T, Iwadate Y, Namba H, Osato K, Saeki N, Yamaura A, Uchida Y : Glucose and methionine uptake and proliferative activity in meningiomas. Neurol Res 21 : 640-644, 1999
21. Karim AB, Afra D, Cornu P, Bleehan N, Schraub S, De Witte O, Darcel F, Stennning S, Pierart M, Van Glabbeke M : Randomized trial on the efficacy of radiotherapy for cerebral low-grade glioma in the adult : European Organization for Research and Treatment of Cancer Study 22845 with the Medical Research Council study BR04 : an interim analysis. Int J Radiat Oncol Biol Phys 52 : 316-324, 2002
22. Kaschten B, Stevenaert A, Sadzot B, Deprez M, Degueldre C, Fiore GD, Luxen A, Reznik M : Preoperative evaluation of 54 gliomas by PET with fluorine-18-fluorodeoxyglucose and/or carbon-11-methinine. J Nucl Med 39 : 778-785, 1998
23. 11C-methionine positron emission tomography. Surg Neurol, Feb 26, 2008 [Epub a head of print]
24. 18F-FDG PET. Eur J Nucl Med Mol Imaging 32 : 52-59, 2005
25. Kracht LW, Bauer A, Herholz K, Terstegge K, Friese M, Schröder R, Heiss WD : Positron emission tomography in a case of intracranial hemangiopericytoma. J Comput Assist Tomogr 23 : 365-368, 1999
26. 11C]-L-methionine uptake as measured by positron emission tomography correlates to microvessel density in patients with glioma. Eur J Nucl Med Mol Imaging 30 : 868-873, 2003
27. 11C] L-methionine positron emission tomography : local comparison with stereotactic histopathology. Clin Cancer Res 10 : 7163-7170, 2004
28. Levivier M, Massager N, Wikler D, Lorenzoni J, Ruiz S, Devriendt D, David P, Desmedt F, Simon S, Van Houtte P, Brotchi J, Glodman S : Use of stereotactic PET images in dosimetry planning of radiosurgery for brain tumors : clinical experience and proposed classification. J Nucl Med 45 : 1146-1154, 2004
29. Miwa K, Shinoda J, Yano H, Okumura A, Iwama T, Nakahashi T, Sakai N : Discrepancy between lesion distributions on methinine PET and MR images in patients with glioblastoma multiforme : insight from a PET and MR fusion image study. J Neurol Neurosurg Psychiatry 75 : 1457-1462, 2004
30. Muhr C : Positron emission tomography in acromegaly and other pituitary adenoma patients. Neuroendocrinology 83 : 205-210, 2006
31. 18F-fDG PET and 99mTc-HMPOA SPECT. Ann Nucl Med 16 : 207-211, 2002
32. 11C] methionine-positron emission tomography as a biological monitoring tool in the treatment of glioma. J Neurosurg 103 : 498-507, 2005
33. 11C] methionine PET in patients with low-grade astrocytoma. Int J Radiat Oncol Biol Phys 48 : 43-52, 2000
34. Nyberg G, Bergström M, Enblad P, Lilja A, Muhr C, Långström B : PET-methionine of skull base neuromas and meningiomas. Acta Otolaryngol 117 : 482-489, 1997
35. Ogawa T, Hatazawa J, Inugami A, Murakami M, Fujita H, Shimosegawa E, Noguchi K, Okudera T, Kanno I, Uemura K, Hadeishi H, Sasajima T : Carbon-11-methinone PET evaluation of intracerebral hematoma : distinguishing neoplastic from nonneoplastic hematoma. J Nucl Med 36 : 2175-2179, 1995
36. 11C-methinone. AJNR Am J Neuroradiol 17 : 345-353, 1996
37. Ogawa T, Kanno I, Hatazawa J, Inugami A, Fijita H, Shimosegawa E, Murakami M, Okudera T, Uemura K, Yasui N, Mineura K : Methionine PET for follow-up of radiation therapy of primary lymphoma of the brain. Radiographics 14 : 101-110, 1994
38. Padma MV, Said S, Jacobs M, Hwang DR, Dunigan K, Satter M, Christian B, Ruppert J : Prediction of pathology and survival by FDG PET in gliomas. J Neurooncol 64 : 227-237, 2003
39. Pirotte B, Glodman S, Dewitte O, Massager N, Wikler D, Lefranc F, Ben Taib NO, Rorive S, David P, Brotchi J, Levivier M : Integrated positron emission tomography and magnetic resonance imaging-guided resection of brain tumors : a report of 103 consecutive procedures. J Neurosurg 104 : 238-253, 2006
40. 11C-methionine in 45 positron emission tomography-guided stereotactic brain biopsies. J Neurosurg 101 : 476-483, 2004
41. 11C-methionine for PET-guided stereotactic brain biopsy of gliomas. J Nucl Med 45 : 1293-1298, 2004
42. 11C] methonine-positron emission tomographic and magnetic resonance imaging for image-guided surgical resection of infiltrative low-grade brain tumor in children. Neurosurgery 57 Suppl 1 : 128-139, 2005
43. 18F] fluorodeoxyglucose PET in the follow-up of glioblastoma multiforme. J Neurooncol 84 : 305-314, 2007
44. 11C-methionine PET as a marker for the radiosensitivity of low grade gliomas. Eur J Nucl Med Mol Imaging 29 : 632-640, 2002
45. 11C-methionine and survival in patients with low-grade gliomas. Cancer 92 : 1541-1549, 2001
46. 11C-methionine PET as a surrogate endpoint after treatment of grade 2 gliomas. J Neurooncol 71 : 325-332, 2005
47. Ricci PE, Karis JP, Heiserman JE, Fram EK, Bice AN, Drayer BP : Differentiating recurrent tumor from radiation necrosis : time for re-evaluation of positron emission tomography? AJNR Am J Neuroradiol 19 : 407-413, 1998
48. Roelcke U, von Amnion K, Hausmann O, Kaech DL, Vanloffeld W, Landolt H, Rem JA, Gratzl O, Radü EW, Leenders KL : Operated low grade astrocytomas : a long term PET study on the effect of radiotherapy. J Neurol Neurosurg Psychiatry 66 : 644-647, 1999
49. Sadeghi N, Salmon I, Decaestecker C, Levivier M, Metens T, Wikler D, Denolin V, Rorive S, Massager N, Baleriaux D, Glodman S : Stereotactic comparison among cerebral blood volume, methionine uptake, and histopathology in brain glioma. AJNR Am J Neuroradiol 28 : 455-461, 2007
50. Sasaki M, Kuwabara Y, Yoshida T, Nakagawa M, Fukumura T, Mihara F, Morioka T, Fukui M, Masuda K : A comparative study of thallium-201 SPET, carbon-11 methionine PET and fluorine-18 fluorodeoxyglucose PET for the differentiation of astrocytic tumours. Eur J Nucl Med 25 : 1261-1269, 1998
51. 11C-methionine positron emission tomography and proliferating cell nuclear antigen staining. Neurosurg Rev 22 : 210-214, 1999
52. 201T1 SPECT for differentiation of recurrent glioma from radiation necrosis. Neurol Med Chir (Tokyo) 38 : 342-348, 1998
53. 11C-methionine PET for the diagnosis and management of recurrent pituitary adenomas. Eur J Nucl Med Mol Imaging 33 : 169-178, 2006
54. Tang BN, Sadeghi N, Branle F, De Witte O, Wikler D, Goldman S : Semi-quantification of methionine uptake and flair signal for the evaluation of chemotherapy in low-grade oligodendroglioma. J Neurooncol 71 : 161-168, 2005
55. 11C-methionine PET for differentiation of recurrent brain tumors from radiation necrosis after radiotherapy. J Nucl Med 49 : 694-699, 2008
56. Tsuyuguchi N, Sunada I, Iwai Y, Yamanaka K, Tanaka K, Takami T, Otsuka Y, Sakamoto S, Ohata K, Goto T, Hara M : Methionine positron emission tomography of recurrent metastatic brain tumor and radiation necrosis after stereotactic radiosurgery : is a differential diagnosis possible? J Neurosurg 98 : 1056-1064, 2003
57. Tsuyuguchi N, Takami T, Sunada I, Iwai Y, Yamanaka K, Tanaka K, Nishikawa M, Ohata K, Torii K, Morino M, Nishio A, Hara M : Methionine positron emission tomography for differentiation of recurrent brain tumor and radiation necrosis after stereotactic radiosurgery-in malignant glioma-. Ann Nucl Med 18 : 291-296, 2004
58. 11C-methionine PET in suspected recurrence of glioma : sensitivity, inter-observer variability and prognostic value. Eur J Nucl Med Mol Imaging 32 : 39-51, 2005